| Mean age (yrs) | 42.22 ± 19.30 | NYHA class |
| ||
| Female | 12 (52.2%) | I | 3 (13.0%) | ||
| Location |
| II | 11 (47.8%) | ||
| Hospital | 14 (60.9%) | III | 8 (34.8%) | ||
| Out-of-hospital | 9 (31.9%) | IV | 1 (4.4%) | ||
| Home | 7 (77.8%) | Medication |
| ||
| Public place | 2 (22.2%) | ACE inhibitors | 22 (95.7%) | ||
| Symptoms experienced |
| Beta blockers | 21 (91.3%) | ||
| Palpitation | 22 (95.7%) | Furosemide | 21 (91.3%) | ||
| Chest pain | 11 (47.8%) | Spironolactone | 16 (69.6%) | ||
| Syncope | 4 (17.4%) | Aspirin | 13 (56.5%) | ||
| Comorbidities |
| Digoxin | 14 (60.9%) | ||
| Heart failure | 19 (82.6%) | Statin | 11 (47.8%) | ||
| Hypertension | 11 (47.8%) | Enoxaparin | 11 (47.8%) | ||
| Diabetes | 5 (21.7%) | Warfarin | 6 (26.1%) | ||
| Dyslipidemia | 4 (30.8%)* | Clopidogrel | 5 (21.7%) | ||
| AF | 4 (17.4%) | Attempt at resuscitation |
| ||
| Alcohol | 2 (8.7%) | Hospital | 12 (85.7%) | ||
| Smoking | 2 (8.7%) | Out-of-hospital | 0 (0%) | ||